MarketCap
Facebook
X
TelegramAnnual report 2021
added 12-23-2023
Burning Rock Biotech Limited Total Inventories 2011-2026 | BNR
Annual Total Inventories Burning Rock Biotech Limited
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| 123 M | 68 M | 58.1 M | - | - | - | - | - | - | - | - |
All numbers in CNY currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 123 M | 58.1 M | 83.1 M |
Quarterly Total Inventories Burning Rock Biotech Limited
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | 123 M | - | - | - | 68 M | - | - | - | 58.1 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in CNY currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 123 M | 58.1 M | 83.1 M |
Total Inventories of other stocks in the Diagnostics research industry
| Issuer | Total Inventories | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Co-Diagnostics
CODX
|
992 K | $ 1.29 | -21.17 % | $ 1.72 M |  USA |
 |
Agilent Technologies
A
|
830 M | $ 111.7 | -1.36 % | $ 34 B | USA |
 |
Castle Biosciences
CSTL
|
10.3 M | $ 19.13 | 1.32 % | $ 555 M | USA |
 |
Aspira Women's Health
AWH
|
256 K | - | -6.19 % | $ 10.5 M | USA |
 |
Accelerate Diagnostics
AXDX
|
5.19 M | - | -61.36 % | $ 2.46 M | USA |
 |
Biocept
BIOC
|
757 K | - | -13.05 % | $ 7.29 M | USA |
 |
Illumina
ILMN
|
547 M | $ 142.54 | -0.49 % | $ 22.7 B | USA |
 |
Interpace Biosciences
IDXG
|
1.11 M | $ 1.76 | -2.22 % | $ 7.79 M | USA |
 |
CareDx, Inc
CDNA
|
26.7 M | $ 19.97 | -2.54 % | $ 1.06 B | USA |
 |
Chembio Diagnostics
CEMI
|
7.72 M | - | 0.22 % | $ 16.8 M | USA |
 |
Lantheus Holdings
LNTH
|
64.7 M | $ 93.91 | -2.86 % | $ 6.34 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
909 K | - | -20.0 % | $ 1.06 M | USA |
 |
Global Cord Blood Corporation
CO
|
45.9 M | - | - | $ 399 M |  China |
 |
Mettler-Toledo International
MTD
|
387 M | $ 1 031.64 | -0.99 % | $ 21.3 B |  Schweiz |
 |
Myriad Genetics
MYGN
|
30.6 M | $ 3.58 | -1.1 % | $ 332 M | USA |
 |
NeoGenomics
NEO
|
28.6 M | $ 8.24 | -1.44 % | $ 1.06 B | USA |
 |
DermTech
DMTK
|
1 M | - | -11.32 % | $ 2.94 M | USA |
 |
Charles River Laboratories International
CRL
|
299 M | $ 150.85 | -5.3 % | $ 7.48 B | USA |
 |
Natera
NTRA
|
35.4 M | $ 186.36 | -5.36 % | $ 18.3 B | USA |
 |
Enzo Biochem
ENZ
|
6.83 M | - | -8.98 % | $ 14.8 K | USA |
 |
Exact Sciences Corporation
EXAS
|
166 M | - | - | $ 19.8 B | USA |
 |
Guardant Health
GH
|
85.9 M | $ 94.92 | -3.79 % | $ 11.9 B | USA |
 |
Heska Corporation
HSKA
|
60 M | - | - | $ 1.31 B | USA |
 |
ICON Public Limited Company
ICLR
|
2.3 M | $ 116.38 | -0.61 % | $ 9.6 B |  Irlanda |
 |
Senseonics Holdings
SENS
|
6.7 M | $ 5.77 | -0.86 % | $ 241 M | USA |
 |
Soleno Therapeutics
SLNO
|
15 M | $ 53.01 | 0.04 % | $ 2.69 B | USA |
 |
QIAGEN N.V.
QGEN
|
302 M | - | - | $ 10.6 B |  Niderland |
 |
Biomerica
BMRA
|
1.49 M | $ 2.34 | -2.9 % | $ 5.38 M | USA |
 |
Laboratory Corporation of America Holdings
LH
|
535 M | $ 250.4 | -1.43 % | $ 20.8 B | USA |
 |
Thermo Fisher Scientific
TMO
|
5.42 B | $ 438.34 | -2.2 % | $ 165 B | USA |
 |
Motus GI Holdings
MOTS
|
496 K | - | -34.28 % | $ 263 K |  Israel |
 |
Twist Bioscience Corporation
TWST
|
28.3 M | $ 49.17 | -7.14 % | $ 2.94 B | USA |
 |
Neogen Corporation
NEOG
|
191 M | $ 8.19 | -2.85 % | $ 1.78 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
189 M | $ 186.61 | -0.71 % | $ 20.7 B | USA |
 |
Invitae Corporation
NVTA
|
30.4 M | - | - | $ 21.2 M | USA |